{{Rsnum
|rsid=8190315
|Gene=BID
|Chromosome=22
|position=17743998
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.05693
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BID
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 96.5 | 3.5 | 0.0
| HCB | 81.8 | 18.2 | 0.0
| JPT | 82.3 | 16.8 | 0.9
| YRI | 87.1 | 12.9 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 81.8 | 18.2 | 0.0
| CHD | 82.6 | 14.7 | 2.8
| GIH | 0.0 | 0.0 | 0.0
| LWK | 78.2 | 21.8 | 0.0
| MEX | 94.8 | 5.2 | 0.0
| MKK | 79.5 | 19.2 | 1.3
| TSI | 94.1 | 5.9 | 0.0
| HapMapRevision=28
}}Previous studies had suggested that the minor allele of this SNP might influence breast cancer. However, a 2009 European study of 30,000 breast cancer cases, compared to 30,000 controls, found no association, or as they put it, "persuasive evidence against an overall association between invasive breast cancer risk and (this SNP)".{{PMID|19423537|OA=1
}}

{{GET Evidence
|gene=BID
|aa_change=Ser56Gly
|aa_change_short=S56G
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8190315
|overall_frequency_n=424
|overall_frequency_d=10758
|overall_frequency=0.0394125
|n_genomes=7
|n_genomes_annotated=0
|n_haplomes=7
|n_articles=0
|n_articles_annotated=0
|nblosum100=2
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=24398548
|Title=Association between BH3 interacting domain death agonist (BID) gene polymorphism and ossification of the posterior longitudinal ligament in Korean population
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}